InMode delivers $92.1 million Q3 revenue, maintains 2026 outlook

InMode (NASDAQ:INMD) reported third-quarter 2026 revenue of US$92.1 million, compared with US$93.2 million in the same period last year, while reaffirming its full-year financial outlook.

Quarterly revenue declined approximately 1.2% year-over-year, while GAAP net income fell to US$18.863 million from US$21.863 million and diluted earnings per share decreased to US$0.32 from US$0.34.

Consumables and service revenue declined 3% to US$19.3 million, while international capital equipment revenue increased and US capital equipment revenue decreased.

GAAP operating margin narrowed to 19% from 22%, although gross margin remained at 78%.

InMode expects full-year 2026 revenue of US$365 million–US$375 million, non-GAAP gross margin of 74%–76%, non-GAAP operating income of US$68 million–US$73 million and non-GAAP diluted earnings per share of US$1.29–US$1.34.

InMode develops minimally invasive aesthetic and medical treatment technologies, including energy-based devices used in skin treatments, body contouring and other medical aesthetic procedures.

The company held US$512.7 million in cash, marketable securities and short-term deposits at September 30, 2026, while its Special Committee completed its work and investor relations activities were set to resume.